Mawallafi: John Stephens
Ranar Halitta: 21 Janairu 2021
Sabuntawa: 21 Nuwamba 2024
Anonim
Tambayi Kwararren: Allurar Ciwon Suga na Biyu - Kiwon Lafiya
Tambayi Kwararren: Allurar Ciwon Suga na Biyu - Kiwon Lafiya

Wadatacce

Mene ne magungunan allura waɗanda ke magance ciwon sukari na 2?

Glucagon-kamar peptide-1 agonists agonists (GLP-1 RAs) su ne magunguna masu allura waɗanda ke kula da ciwon sukari na 2.

Kama da insulin, ana yi musu allura a ƙarƙashin fata. GLP-1 RAs anfi amfani dasu gaba ɗaya tare da sauran magungunan ciwon sikari.

A halin yanzu, akwai GLP-1 RAs da yawa akan kasuwa waɗanda suka bambanta ta tsarin jadawalin da tsawon lokacin aiki. Sun hada da:

  • ƙari (Byetta)
  • exenatide - fadada sako (Bydureon)
  • dulaglutide (Gaskiya)
  • semaglutide (Ozempic) - kuma ana samunsa a tsarin kwamfutar hannu (Rybelsus)
  • liraglutide (Victoza)
  • lixisenatide (Adlyxin)

Pramlintide (Symlin) wani magani ne na allura da aka yarda dashi don magance ciwon sukari na 2. Ana amfani dashi tare da ɗaukar insulin lokacin cin abinci. Kodayake ba a saba amfani dashi ba, yana aiki kamar GLP-1 RAs.

Shin injectable yana haifar da asarar nauyi? Karuwar nauyi?

Sabanin insulin da sauran magungunan sikari, allura ba sa haifar da kiba.


Saboda sun rage yawan ci, wataƙila suna iya taimakawa ga ragin nauyi a cikin kewayon fam 3.3 (kilogiram 1.5) zuwa fam 6.6 (kilogiram 3). Adadin asarar nauyi ya dogara da dalilai da yawa, kamar:

  • rage cin abinci
  • motsa jiki
  • amfani da wasu magunguna

Saboda wannan, GLP-1 RAs sun dace sosai da mutanen da suka yi ƙiba ko suke da kiba. Sau da yawa ana amfani dasu tare da wasu magunguna ko insulin don rage ƙaruwar nauyi.

Shin sashi daidai yake da allura? Shin zan iya yin allurar da kaina?

Ana samun GLP-1 RAs a cikin ruɓaɓɓun alkalami da kuke yiwa kanku kulawa, ta hanya iri ɗaya kamar insulin. Sun bambanta da sashi da tsawon lokacin aiki.

Babu halin gwaji na gwadawa wanda ke nuna yadda zaɓin magani ke shafar sakamakon haƙuri na dogon lokaci.

Kullum likitanku zai fara muku da ƙananan sashi. Wannan zai karu sannu-sannu gwargwadon haƙuri da tasirin da ake so.

Byetta shine kawai wakilin da ake buƙatar gudanarwa sau biyu a rana. Sauran sune allurar yau da kullun ko mako-mako.


Shin akwai sakamako masu illa ga magungunan allura da ya kamata in sani?

Illolin cututtukan ciki, kamar tashin zuciya, amai, da gudawa, na faruwa ne ga marasa lafiya da yawa. Tashin zuciya na iya rage lokaci ko ta hanyar rage maganin. Hakanan yana iya faruwa ƙasa da ƙasa tare da wakilan mako-mako.

Wasu rahotanni sun danganta mai tsananin cutar sanyin jiki tare da GLP-1 RAs, amma babu isassun bayanai don kafa alaƙar sabbaba bayyananniya. Bincike ya binciko wasu illolin da ke tattare da cutar sankara, kamar su cutar sankara, amma babu cikakkiyar shaida.

Wasu GLP-1 RAs na iya haifar da halayen fata na gida a wurin allurar. Wasu mutanen da ke yin amfani da kayan abinci (Bydureon, Byetta) sun ba da rahoton wannan tasirin.

Hypoglycemia ba safai yake faruwa tare da GLP-1 RAs lokacin amfani dashi shi kaɗai. Koyaya, ƙara su zuwa hanyoyin kwantar da insulin na iya ƙara haɗari.

A cikin karatun rodent, an sami ƙaruwa a cikin cututtukan thyroid. Ba a taɓa samun irin wannan tasirin a cikin mutane ba.

Waɗanne irin canje-canje na rayuwa zan yi ban da fara magani?

Canjin rayuwa ga mutanen da ke da ciwon sukari na 2 na iya ƙunsar:


  • gyaggyara abinci
  • rasa kashi 5 zuwa 10 na nauyin jiki, ga wadanda suka yi kiba ko kiba
  • motsa jiki na tsawon minti 150 a mako
  • sa-ido kan sikari na jini
  • iyakance barasa ga abin sha daya a kowace rana ga matan manya da kuma abin sha biyu a rana ga manya
  • ba shan sigari ko barin shan sigari ba

Ana amfani da hanyar farantin farafan suga don ba da jagora game da tsarin abinci da kuma taimakon gani.

Ganin likitan abinci mai rijista na iya taimaka maka jagora zuwa ƙoshin lafiya. Masanin ilimin abinci zai iya ba da shawarar tsarin abinci na musamman wanda ke ba da takamaiman abubuwan da kuke so da abubuwan da kuke so.

Gabaɗaya, rage yawan cin abincin ku na carbohydrate wajibi ne don inganta kula da sukarin jini.

Zabi carbs waɗanda suke:

  • mai gina jiki-mai yawa
  • high a cikin fiber
  • kadan sarrafawa

Sauya abubuwan sha mai zaki da ruwa.

Bugu da ƙari, cin abinci mai wadataccen mai da ƙwayoyin polyunsaturated na iya inganta haɓakar glucose da ƙananan haɗarin zuciya da jijiyoyin jini.

Nawa ne kudin allurar injecti? Shin yawanci an rufe su a karkashin inshora?

Injectin GLP-1 RAs da pramlintide (Symlin) suna da tsada. Babu zaɓuɓɓukan zaɓi a halin yanzu. Matsakaicin farashin babban kwastomomi kamar haka:

  • Enasashen waje: $ 840
  • Dulaglutide: $ 911
  • Semaglutide: $ 927
  • Liraglutide: $ 1,106
  • Lixisenatide: $ 744
  • Pramlintide: $ 2,623

Wadannan an rufe su da tsare-tsaren inshora da yawa. amma jagororin manufofin, keɓancewa, buƙatun don maganin mataki, da izini kafin izini sun bambanta sosai.

Yana da mahimmanci don saba da ƙayyadaddun tsarin maganin likitan ku.

Dokta Maria S. Prelipcean likita ce da ta kware a ilimin endocrinology da ciwon suga. A yanzu haka tana aiki a Southview Medical Group a Birmingham, Alabama. Dr. Prelipcean ya kammala karatun sa ne a Makarantar Kiwon Lafiya ta Carol Davila da ke Bucharest, Romania. Ta kammala karatunta na likitanci na ciki a Jami'ar Illinois da Northwest University a Chicago da kuma ilimin ilimin ilimin kimiyya a Jami'ar Alabama a Birmingham. Dr. Prelipcean an maimaita masa suna a matsayin Babban Likitan Birmingham kuma shi ɗan'uwan Kwalejin Kwalejin Ilimin Endocrinology na Amurka. A lokacin hutu, tana jin daɗin karatu, tafiye-tafiye, da kuma kasancewa tare da iyalinta.

Selection

Dabigatran

Dabigatran

Idan kana da fibrillation na atrial (yanayin da zuciya ke bugawa ba bi a ka'ida ba, da kara damar da karewa a jiki, da kuma yiwuwar haifar da hanyewar jiki) kuma kana han dabigatran don taimakawa ...
Allurar Reslizumab

Allurar Reslizumab

Allurar Re lizumab na iya haifar da halayen ra hin lafiyar mai t anani ko barazanar rai. Kuna iya fu kantar halin ra hin lafiyan yayin da kuke karɓar jiko ko na ɗan gajeren lokaci bayan jiko ya ƙare.Z...